Professional Summary
I’m an infectious disease and data scientist advancing public health
through ethical, FAIR, and impactful data sharing. At Vivli, I lead
member engagement and strategic planning for the Antimicrobial
Resistance (AMR) Register and serve as a subject matter expert in data
governance and international data sharing. My work bridges researchers,
clinicians, and data scientists to drive innovation in health equity,
AI ethics, and open science.
Education
PhD in Infectious Diseases
2022
University of Georgia
MS in Epidemiology & Biostatistics
2022
University of Georgia
BS in Microbiology
2014
University of Wisconsin–Madison
BS in Botany
2014
University of Wisconsin–Madison
Interests
Data governance & FAIR / CARE / TRUST data sharing
Antimicrobial resistance (AMR) surveillance
Responsible AI / ML & data ethics
Program & portfolio management
What I work on
I help research and data-sharing programs run well. That means turning complex, multi-stakeholder initiatives into documented, metrics-driven operations, and translating fluently between scientists, engineers, policy staff, and leadership.
My focus areas are antimicrobial resistance (AMR) surveillance data, FAIR and responsible data governance, and the ethical use of AI and machine learning in public health. I care about inclusive research design and building the trust that makes data reuse possible.
Publications
(2025).
Different antigenic distance metrics generate similar predictions of influenza vaccine response breadth despite moderate correlation.
medRxiv.
(2025).
Exploring bias due to below-limit-of-detection values in influenza vaccine antibody modeling: A case study and instructional guide for the CIVIC study.
Vaccine.
(2025).
High-Dose Inactivated Influenza Vaccine Inconsistently Improves Heterologous Antibody Responses in an Older Human Cohort.
The Journal of Infectious Diseases.
(2024).
Cancer screening with multicancer detection tests: A translational science review.
CA: A Cancer Journal for Clinicians.
(2024).
COBRA N2 NA vaccines induce protective immune responses against influenza viral infection.
Human Vaccines & Immunotherapeutics.